24 Jan 2018 17:44
For immediate release
TYRATECH, INC.
Β
("TyraTech" or the "Company")
Holding(s) in Company
TyraTech Inc. (AIM: TYR, and TYRU), the life sciences company focused on nature-derived insect and parasite control products, was informed on 23 January 2018, that following the retirement of shares on 8 January as a result of the Tender Offer (announced on 5 January 2017), Alan Reade no longer has a notifiable interest in the Company's issued share capital.
-ends-
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meaning as defined in the Circular.
Β The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
For further information:
Β
TyraTech Inc. Bruno Jactel, Chief Executive Officer Erica H. Boisvert, Chief Financial Officer www.tyratech.com | Β Tel: +1 919 415 4340 Tel: +1 919 415 4287 |
Β SPARK Advisory Partners Limited (Nominated Adviser) Matt Davis / Mark Brady | Β Β Β Tel: +44 20 3368 3551 |
Β Allenby Capital Limited (Broker) Chris Crawford | Β Β Tel: +44 20 3328 5656 |
Β | Β |
Belvedere Communications (PR) John West / Kim van Beeck | Β Tel: +44 20 3567 0510 |
Β
Follow the stocks